Search

Seung H. Lee

Examiner (ID: 8709, Phone: (571)272-2401 , Office: P/2887 )

Most Active Art Unit
2876
Art Unit(s)
2887, 2876
Total Applications
2203
Issued Applications
1831
Pending Applications
152
Abandoned Applications
248

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5023543 [patent_doc_number] => 20070149509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Use of vitamin e' [patent_app_type] => utility [patent_app_number] => 10/582906 [patent_app_country] => US [patent_app_date] => 2004-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1073 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20070149509.pdf [firstpage_image] =>[orig_patent_app_number] => 10582906 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/582906
Use of vitamin e Dec 8, 2004 Abandoned
Array ( [id] => 6931876 [patent_doc_number] => 20050282911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Memantine for the prevention or reduction of suicidality and for treatment of major depression associated with suicidality' [patent_app_type] => utility [patent_app_number] => 11/006487 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6236 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282911.pdf [firstpage_image] =>[orig_patent_app_number] => 11006487 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/006487
Memantine for the prevention or reduction of suicidality and for treatment of major depression associated with suicidality Dec 5, 2004 Abandoned
Array ( [id] => 281858 [patent_doc_number] => 07553858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Combination of flupirtine and tramadol' [patent_app_type] => utility [patent_app_number] => 11/002762 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4009 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553858.pdf [firstpage_image] =>[orig_patent_app_number] => 11002762 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/002762
Combination of flupirtine and tramadol Dec 2, 2004 Issued
Array ( [id] => 5716151 [patent_doc_number] => 20060079514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Methods and compositions including methscopolamine bromide' [patent_app_type] => utility [patent_app_number] => 11/001748 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2610 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079514.pdf [firstpage_image] =>[orig_patent_app_number] => 11001748 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/001748
Methods and compositions including methscopolamine bromide Dec 1, 2004 Abandoned
Array ( [id] => 7050401 [patent_doc_number] => 20050186288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions' [patent_app_type] => utility [patent_app_number] => 10/999988 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9139 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186288.pdf [firstpage_image] =>[orig_patent_app_number] => 10999988 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/999988
Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions Nov 30, 2004 Abandoned
Array ( [id] => 6918738 [patent_doc_number] => 20050096299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Method for inhibiting bone resorption' [patent_app_type] => utility [patent_app_number] => 11/000199 [patent_app_country] => US [patent_app_date] => 2004-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10015 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096299.pdf [firstpage_image] =>[orig_patent_app_number] => 11000199 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/000199
Method for inhibiting bone resorption Nov 29, 2004 Abandoned
Array ( [id] => 5142508 [patent_doc_number] => 20070004724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => '(+)-(2S,3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinor for treating anxiety' [patent_app_type] => utility [patent_app_number] => 10/595916 [patent_app_country] => US [patent_app_date] => 2004-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5064 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004724.pdf [firstpage_image] =>[orig_patent_app_number] => 10595916 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/595916
(+)-(2S,3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinor for treating anxiety Nov 24, 2004 Abandoned
Array ( [id] => 860529 [patent_doc_number] => 07371756 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-13 [patent_title] => 'Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts' [patent_app_type] => utility [patent_app_number] => 10/994226 [patent_app_country] => US [patent_app_date] => 2004-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9739 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371756.pdf [firstpage_image] =>[orig_patent_app_number] => 10994226 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/994226
Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts Nov 22, 2004 Issued
Array ( [id] => 5189141 [patent_doc_number] => 20070167450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Agent for treating chronic pelvic pain syndrome' [patent_app_type] => utility [patent_app_number] => 10/580417 [patent_app_country] => US [patent_app_date] => 2004-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4536 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167450.pdf [firstpage_image] =>[orig_patent_app_number] => 10580417 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/580417
Agent for treating chronic pelvic pain syndrome Nov 17, 2004 Abandoned
Array ( [id] => 5022227 [patent_doc_number] => 20070148193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Lutein concentrate' [patent_app_type] => utility [patent_app_number] => 10/576272 [patent_app_country] => US [patent_app_date] => 2004-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1113 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20070148193.pdf [firstpage_image] =>[orig_patent_app_number] => 10576272 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/576272
Lutein concentrate Nov 17, 2004 Abandoned
Array ( [id] => 6906260 [patent_doc_number] => 20050101655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Migraine treatments including isovaleramide compounds and serotonin agonists' [patent_app_type] => utility [patent_app_number] => 10/987760 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5062 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101655.pdf [firstpage_image] =>[orig_patent_app_number] => 10987760 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/987760
Migraine treatments including isovaleramide compounds and serotonin agonists Nov 11, 2004 Abandoned
Array ( [id] => 6911930 [patent_doc_number] => 20050175688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Method of treating pain in a subject by the administration of aminobenzoate potassium' [patent_app_type] => utility [patent_app_number] => 10/970542 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4094 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20050175688.pdf [firstpage_image] =>[orig_patent_app_number] => 10970542 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/970542
Method of treating pain in a subject by the administration of aminobenzoate potassium Oct 21, 2004 Abandoned
Array ( [id] => 7143027 [patent_doc_number] => 20050118286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Compositions and methods for treatment of nervous system disorders' [patent_app_type] => utility [patent_app_number] => 10/972188 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 43057 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118286.pdf [firstpage_image] =>[orig_patent_app_number] => 10972188 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/972188
Compositions and methods for treatment of nervous system disorders Oct 21, 2004 Abandoned
Array ( [id] => 7005893 [patent_doc_number] => 20050171206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Therapeutical use' [patent_app_type] => utility [patent_app_number] => 10/971527 [patent_app_country] => US [patent_app_date] => 2004-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7007 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171206.pdf [firstpage_image] =>[orig_patent_app_number] => 10971527 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/971527
Therapeutical use Oct 20, 2004 Abandoned
Array ( [id] => 5085042 [patent_doc_number] => 20070275093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Methods for Treating Non-Microbial Inflammatory Skin Conditioners' [patent_app_type] => utility [patent_app_number] => 10/576396 [patent_app_country] => US [patent_app_date] => 2004-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8848 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275093.pdf [firstpage_image] =>[orig_patent_app_number] => 10576396 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/576396
Methods for Treating Non-Microbial Inflammatory Skin Conditioners Oct 18, 2004 Abandoned
Array ( [id] => 6939882 [patent_doc_number] => 20050113445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Methods of treating mental diseases, inflammation and pain' [patent_app_type] => utility [patent_app_number] => 10/967954 [patent_app_country] => US [patent_app_date] => 2004-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1793 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113445.pdf [firstpage_image] =>[orig_patent_app_number] => 10967954 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/967954
Methods of treating mental diseases, inflammation and pain Oct 18, 2004 Abandoned
Array ( [id] => 5716150 [patent_doc_number] => 20060079513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Methods and compositions including methscopolamine nitrate' [patent_app_type] => utility [patent_app_number] => 10/964252 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2934 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079513.pdf [firstpage_image] =>[orig_patent_app_number] => 10964252 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/964252
Methods and compositions including methscopolamine nitrate Oct 12, 2004 Abandoned
Array ( [id] => 5715264 [patent_doc_number] => 20060078627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Composition for treatment of obesity or generally aiding weight loss in pill, powder or liquid form, by appetite reduction and metabolism increase, comprising: L- phenylalanine, caffeine, and one or more of the group of all forms of 5-hydroxytryptophan and L-tryptophan, all from either natural or synthetic sources' [patent_app_type] => utility [patent_app_number] => 10/959973 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2008 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20060078627.pdf [firstpage_image] =>[orig_patent_app_number] => 10959973 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/959973
Composition for treatment of obesity or generally aiding weight loss in pill, powder or liquid form, by appetite reduction and metabolism increase, comprising: L- phenylalanine, caffeine, and one or more of the group of all forms of 5-hydroxytryptophan and L-tryptophan, all from either natural or synthetic sources Oct 7, 2004 Abandoned
Array ( [id] => 6939886 [patent_doc_number] => 20050113449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Enhanced efficacy of omega-3 fatty acid therapy in the treatment of psychiatric disorders and other indications' [patent_app_type] => utility [patent_app_number] => 10/961288 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3425 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113449.pdf [firstpage_image] =>[orig_patent_app_number] => 10961288 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/961288
Enhanced efficacy of omega-3 fatty acid therapy in the treatment of psychiatric disorders and other indications Oct 7, 2004 Abandoned
Array ( [id] => 5720398 [patent_doc_number] => 20060073172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure' [patent_app_type] => utility [patent_app_number] => 10/956865 [patent_app_country] => US [patent_app_date] => 2004-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6185 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073172.pdf [firstpage_image] =>[orig_patent_app_number] => 10956865 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/956865
Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure Sep 30, 2004 Abandoned
Menu